Crinetics Pharmaceuticals Inc (CRNX): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 02.09.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 85 US Dollar | 11 | 5 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 106.095.205 | 7,26 | 2,26 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Crinetics Pharmaceuticals Inc
Mitarbeiter 594
Handelsplatz PINK
Ticker Symbol CRNX
IPO Datum 2018-07-18
Adresse 6055 Lusk Boulevard, San Diego, CA, United States, 92121
Webseite https://www.crinetics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. R. Scott Struthers Ph.D. | Founder, President, CEO & Director |
| 2 | Dr. Stephen F. Betz Ph.D. | Co-Founder & Chief Scientific Officer |
| 3 | Mr. Tobin C. Schilke | Chief Financial Officer |
| 4 | Mr. Kea Lingo | Chief Information Officer |
| 5 | Ms. Gayathri Diwakar | Head of Investor Relations |
| 6 | Ms. Garlan Adams J.D. | Chief Legal Officer & Corporate Secretary |
| 7 | Natalie Badillo | Head of Corporate Communications |
| 8 | Ms. Adriana C. Cabre M.B.A. | Chief Human Resources Officer |
| 9 | Dr. Alan S. Krasner M.D. | Chief Endocrinologist |
| 10 | Mr. Kevin Capps | Head of Intellectual Property |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 14,85% | 1,34 Mrd. USD |
| 2 | BlackRock Inc | 7,99% | 0,72 Mrd. USD |
| 3 | Farallon Capital Management, L.L.C. | 7,86% | 0,71 Mrd. USD |
| 4 | Wellington Management Company LLP | 6,72% | 0,61 Mrd. USD |
| 5 | Driehaus Capital Management LLC | 6,03% | 0,54 Mrd. USD |
| 6 | T. Rowe Price Associates, Inc. | 5,05% | 0,46 Mrd. USD |
| 7 | Vanguard Capital Management, LLC | 4,41% | 0,40 Mrd. USD |
| 8 | Vanguard Portfolio Management, LLC | 4,37% | 0,39 Mrd. USD |
| 9 | HHG PLC | 4,26% | 0,38 Mrd. USD |
| 10 | Bellevue Group AG | 3,09% | 0,28 Mrd. USD |
| 11 | Geode Capital Management, LLC | 2,34% | 0,21 Mrd. USD |
| 12 | State Street Corp | 2,27% | 0,20 Mrd. USD |
| 13 | Baker Bros Advisors LP | 2,22% | 0,20 Mrd. USD |
| 14 | Pictet Asset Manangement SA | 1,96% | 0,18 Mrd. USD |
| 15 | T. Rowe Price Investment Management,Inc. | 1,83% | 0,17 Mrd. USD |
| 16 | Siren, L.L.C. | 1,79% | 0,16 Mrd. USD |
| 17 | BNP Paribas Investment Partners SA | 1,62% | 0,15 Mrd. USD |
| 18 | GW&K Investment Management, LLC | 1,53% | 0,14 Mrd. USD |
| 19 | Novo A/S | 1,46% | 0,13 Mrd. USD |
| 20 | RTW INVESTMENTS, LLC | 1,37% | 0,12 Mrd. USD |